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Background: the presence of bundle-branch block (BBB) in patients with ST-segment elevation myocardial infarction (STEMI) has been associated 
with a poor outcome. However, the implications of BBB in patients undergoing primary angioplasty in the stent era are poorly established. 
Furthermore, the prognostic implications of BBB type (right versus left and previous versus transient or persistent) remain unknown.
Methods: 913 consecutive patients with STEMI treated with primary angioplasty were analyzed. All clinical, ECG and angiographic data were 
prospectively collected. Median follow-up was 19 months. The primary endpoint was the combined outcome of death and reinfarction.
Results: BBB was documented in 140 patients (15.3%). Right (R) BBB was present in 119 patients (13%): previous in 27 (22.7%), persistent in 45 
(37.8%) and transient in 47 (39.5%). Left (L) BBB was present in 21 patients (2.3%): previous in 8 (38.1%), persistent in 9 (42.9%) and transient 
in 4 (19.0%). Patients with BBB were older, more frequently diabetics, with anterior infarctions, higher Killip class, lower left ventricular ejection 
fraction, and higher mortality (all p<0.005) than patients without BBB. The short and long-term primary outcome occurred more frequently in 
patients with persistent RBBB/LBBB, than in those with previous or transient RBBB/LBBB. On multivariate analysis, persistent RBBB/LBBB emerged 
as independent predictors of death and reinfarction.
Conclusions: in patients undergoing primary angioplasty in the stent era, BBB is associated with poor short and long-term prognosis. This risk 
appears to be particularly high among patients with persistent BBB.
